{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:08:09Z","timestamp":1793689689891,"version":"4.5.1"},"reference-count":12,"publisher":"The Japanese Society for Medical Mycology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.3314\/mmj.25-00042","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T22:12:44Z","timestamp":1780179164000},"page":"97-101","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Hepatic and Renal Function Algorithms for Fosravuconazole in Real-World Clinical Practice"],"prefix":"10.3314","volume":"67","author":[{"given":"Harunari","family":"Shimoyama","sequence":"first","affiliation":[{"name":"Mizonokuchi Dermatology and Medical Mycology Clinic"},{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"},{"name":"Teikyo University Institute of Medical Mycology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Sei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mochizuki T, Tsuboi R, Iozumi K, Ishizaki S, Ushigami T, Ogawa Y, et al: Guidelines for the management of dermatomycosis (2019).  J Dermatol 47: 1343–73, 2020.","DOI":"10.1111\/1346-8138.15618"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Harada K, Hashimoto T, Miyama H: A web-based questionnaire survey of onychomycosis treatment by Japanese dermatologists. J JOCD 40: 44–53, 2023. [Article in Japanese]","DOI":"10.3812\/jocd.40.44"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hata Y, Ueda Y, Hattori N, Naka W, Etoh T: Large-scale epidemiological survey on the actual situation and latent morbidity of tinea pedis and tinea unguium (Foot Check 2023). J JOCD 41: 66–76, 2024. [Article in Japanese]","DOI":"10.3812\/jocd.41.66"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Watanabe S, Tsubouchi I, Okubo A: Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study. J Dermatol 45: 1151–9, 2018.","DOI":"10.1111\/1346-8138.14607"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Okubo A, Hanada M, Kodama S, Taniguchi N, Miyazaki Y: Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patients. J Dermatol 51: 1091–7, 2024.","DOI":"10.1111\/1346-8138.17254"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Uchida H, Kamata M, Ishikawa T, Ito M, Watanabe A, Egawa S, et al: Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single-centre retrospective study.  J Eur Acad Dermatol Venereol 37: e1455–7, 2023.","DOI":"10.1111\/jdv.19363"},{"key":"7","unstructured":"7) Tsunemi Y, Harada K, Igarashi A, Okubo A, Arase Y: Algorithm for liver function tests during administration of fosravuconazole L-lysine ethanolate, a new oral azole antifungal agent. Prog Med 39: 347–51, 2019. [Article in Japanese]"},{"key":"8","unstructured":"8) Kaname S, Tsunemi Y, Nonaka Y: Renal function abnormalities and clinical management with fosravuconazole: A post-hoc analysis of a phase III trial. Shinryo to Shinyaku 62: 241–50, 2025. [Article in Japanese]"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al:  Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982–92, 2009.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"10","unstructured":"10) LiverTox: Clinical and research information on drug-induced liver injury. National Institute of Diabetes and Digestive and Kidney Diseases, 2012. LiverTox Database. (Updated 25 September 2025). Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/ (accessed on 20 October 2025)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sato T, Kobayashi H, Okaniwa A, Okada M: Diagnosis of onychomycosis and real-world data of oral fosravuconazole in Japan. Med Mycol J 66: 147–9, 2025.","DOI":"10.3314\/mmj.25.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Naka W, Tsunemi Y: Effects of additional oral fosravuconazole l-lysine ethanolate therapy following inadequate response to initial treatment for onychomycosis: A multicenter, randomized controlled trial. J Dermatol 51: 964–72, 2024.","DOI":"10.1111\/1346-8138.17193"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/67\/2\/67_97\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:28:51Z","timestamp":1780716531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/67\/2\/67_97\/_article"}},"subtitle":["A Retrospective Study of 128 Cases in a Dermatology Clinic"],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.25-00042","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}